Steve serves on the management team of ILSE and is responsible for the financial reporting and management of ILSE and operational support of the ATCC Center for Translational Microbiology and ILSE’s tenant companies. Steve joined ILSE in July 2015 in the role of Director of Finance and Operations.
Steve began his career with Johnson & Johnson in various finance roles across the pharma group including global pharma R&D where he gained an intimate knowledge of clinical drug development. He then joined Agennix (formerly GPC Biotech) as senior manager of drug development finance as they pursued various early stage and clinical phase I, II & III oncology based programs. Most recently Steve was Director of Finance/Controller for Lux Biosciences, Inc., a venture backed biotechnology company working on phase III development of an immunosuppressant for ophthalmic indications.
Steve has taught Judgment and Decision Making at Montclair State University and is active in the life science community and the economic policy and professional finance community in both NJ & NYC. He serves on the Talent Advisory Committee of BioNJ and the Steering Committee of the CFO Leadership Council.
Steve earned a B.S. in Accounting from Rutgers Business School, B.A. in Psychology from Rutgers College, and a M.A. in Industrial/Organizational Psychology from Montclair State University.